The 5‐HT2A receptor antagonist M100,907 prevents extracellular glutamate rising in response to NMDA receptor blockade in the mPFC
Open accessAbstract
We recently found that intracortical injection of the selective and competitive N‐methyl‐d‐aspartate (NMDA) receptor antagonist 3‐(R)‐2‐carboxypiperazin‐4‐propyl‐1‐phosphonic acid (CPP) impaired attentional performance in rats and blockade of 5‐hydroxytryptamine (5‐HT)2A receptors antagonized this effect. Here, we used the microdialysis technique in conscious rats to study the effect of CPP on extracellular glutamate (GLU) in the medial prefrontal cortex (mPFC) and the regulation of this effect by 5‐HT 2A receptors. Intraperitoneal injection of 20 mg/kg CPP increased extracellular GLU in the mPFC (201% of basal levels) but had no effect on 5‐HT. Intracortical infusion of 100 µ m CPP increased extracellular GLU (230% of basal values) and 5‐HT (150% of basal values) in the mPFC, whereas 30 µ m had no significant effect. The effect of 100 µ m CPP on extracellular GLU was abolished by tetrodotoxin, suggesting that neuronal activity is required. Subcutaneous injection of 40 µg/kg M100,907 completely antagonized the effect of 100 µ m cpp on extracellular GLU, whereas 10 µg/kg caused only partial attenuation. Likewise, intracortical infusion of 0.1 µ m M100,907 completely reversed the increase of extracellular GLU induced by CPP. These findings show that blockade of NMDA receptors in the mPFC is sufficient to increase extracellular GLU locally. The increase of cortical extracellular GLU may contribute to CPP‐induced cognitive deficits and blockade of 5‐HT 2A receptors may provide a molecular mechanism for reversing these deficits caused by dysfunctional glutamatergic transmission in the mPFC.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
M100907 prevents (R)-CPP-induced increases in premature responding.
“administration of the serotonin 5-HT2A receptor antagonist M100907 prevents increases in premature responding induced by MK-801 (Higgins et al 2003) and (R)-CPP (Ceglia et al 2004).”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Ceglia et al 2004
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585 · see citing works
Ledent, C. A., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Impérato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,612 · see citing works
A review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,150 · see citing works
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904 · see citing works
Azmitia, E. C., & Segal, M. (1978) · The Journal of Comparative Neurology · doi:10.1002/cne.901790311 · Cited by 1,908 · see citing works
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793 · see citing works
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685 · see citing works
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308 · see citing works
Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in Rats
Moghaddam, B., & Adams, B. W. (1998) · Science · doi:10.1126/science.281.5381.1349 · Cited by 1,006 · see citing works
Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors
Cartmell, J., & Schoepp, D. D. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750889.x · Cited by 883 · see citing works
Pompeiano, M., Palacios, J. M., & Mengod, G. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90223-2 · Cited by 870 · see citing works
Projections from the amygdaloid complex to the cerebral cortex and thalamus in the rat and cat
Krettek, J. E., & Price, J. L. (1977) · Journal of Comparative Neurology · doi:10.1002/cne.901720408 · Cited by 785 · see citing works
Groenewegen, H. J. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90339-9 · Cited by 732 · see citing works
Araneda, R. C., & Andrade, R. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90128-b · Cited by 621 · see citing works
The Origin and Neuronal Function ofIn VivoNonsynaptic Glutamate
Baker, D. L., Xi, Z., Shen, H., Swanson, C. J., & Kalivas, P. W. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-20-09134.2002 · Cited by 584 · see citing works
Jakab, R. L., & Goldman-Rakic, P. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.735 · Cited by 536 · see citing works
Robinson, T. E., & Whishaw, I. Q. (1988) · Brain Research · doi:10.1016/0006-8993(88)91560-0 · Cited by 520 · see citing works
Aghajanian, G. K., & Marek, G. J. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00051-8 · Cited by 516 · see citing works
Kapur, S., & Seeman, P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001093 · Cited by 459 · see citing works
[3H]MK‐801 Labels a Site on the N‐Methyl‐D‐Aspartate Receptor Channel Complex in Rat Brain Membranes
Wong, E. H. F., Knight, A. R., & Woodruff, G. N. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb13260.x · Cited by 454 · see citing works
Lorrain, D. S., Baccei, C. S., Bristow, L. J., Anderson, J. J., & Varney, M. A. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00652-8 · Cited by 432 · see citing works
Adams, B. W., & Moghaddam, B. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-14-05545.1998 · Cited by 388 · see citing works
Aghajanian, G. K., & Marek, G. J. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01224-x · Cited by 376 · see citing works
Kehne, J. H., Baron, B. M., Carr, A. A., Chaney, S., Elands, J., Feldman, D. J., Frank, R. A., van Giersbergen, P. L. M., McCloskey, T. C., Johnson, M., et al. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12956-x · Cited by 359 · see citing works
Donzanti, B. A., & Yamamoto, B. K. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90267-6 · Cited by 355 · see citing works
Martín‐Ruiz, R., Puig, M. V., Celada, P., Shapiro, D. A., Roth, B. L., Mengod, G., & Artigas, F. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09856.2001 · Cited by 338 · see citing works
Invernizzi, R. W., Belli, S., & SAMANIN, R. (1992) · Brain Research · doi:10.1016/0006-8993(92)90914-u · Cited by 275 · see citing works
Self-citationCartmell, J., Monn, J. A., & Schoepp, D. D. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35084-0 · Cited by 270 · see citing works
Berretta, N., & Jones, R. S. G. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00301-6 · Cited by 264 · see citing works
Nicotine Induces Glutamate Release from Thalamocortical Terminals in Prefrontal Cortex
Lambe, E. K., Picciotto, M. R., & Aghajanian, G. K. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300032 · Cited by 261 · see citing works
Aoki, C. J., Venkatesan, C., Go, C. G., Mong, J., & Dawson, T. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-09-05202.1994 · Cited by 255 · see citing works
Lehmann, J. C., Schneider, J. A., McPherson, S. E., Murphy, D. E., Bernard, P. S., Tsai, C., Bennett, D. A., Pastor, G., Steel, D. J., & Boehm, C. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-5347(25)00366-0 · Cited by 237 · see citing works
Winstanley, C. A., Chudasama, Y., Dalley, J. W., Theobald, D. E. H., Glennon, J. C., & Robbins, T. W. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1398-x · Cited by 234 · see citing works
Dopaminergic Modulation of Glutamate Release in Striatum as Measured by Microdialysis
Yamamoto, B. K., & Davy, S. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10048.x · Cited by 228 · see citing works
Noda, Y., Yamada, K., Furukawa, H., & Nabeshima, T. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb15106.x · Cited by 224 · see citing works
Puig, M. V. (2003) · Cerebral Cortex · doi:10.1093/cercor/13.8.870 · Cited by 223 · see citing works
Miner, L. A. H., Backstrom, J. R., Sanders-Bush, E., & Sesack, S. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00580-8 · Cited by 216 · see citing works
Amygdala input to medial prefrontal cortex (mPFC) in the rat: A light and electron microscope study
Bacon, S. J., Headlam, A. J. N., Gabbott, P. L. A., & Smith, A. D. (1996) · Brain Research · doi:10.1016/0006-8993(96)00155-2 · Cited by 191 · see citing works
Gioanni, Y., Rougeot, C., Clarke, P. B. S., Lepousé, C., Thierry, A. M., & Vidal, C. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00403.x · Cited by 191 · see citing works
Berridge, C. W., Stratford, T. R., Foote, S. L., & Kelley, A. E. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199711)27:3 · Cited by 188 · see citing works
Jay, T. M., Thierry, A., Wiklund, L., & Glowinski, J. (1992) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1992.tb00154.x · Cited by 187 · see citing works
BACLOFEN: EFFECTS ON AMINO ACID RELEASE AND METABOLISM IN SLICES OF GUINEA PIG CEREBRAL CORTEX
Potashner, S. J. (1979) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1979.tb04516.x · Cited by 182 · see citing works
Higgins, G. A., Enderlin, M., Haman, M., & Fletcher, P. J. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1549-0 · Cited by 179 · see citing works
Gobert, A., & Millan, M. J. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00188-9 · Cited by 171 · see citing works
Herrera‐Marschitz, M., You, Z. ‐., Goiny, M., et al. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66041726.x · Cited by 167 · see citing works
Miyamoto, Y., Yamada, K., Noda, Y., Mori, H., Mishina, M., & Nabeshima, T. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00750.2001 · Cited by 158 · see citing works
5-HT2 Receptor Regulation of Extracellular GABA Levels in the Prefrontal Cortex
Abi‐Saab, W. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00046-3 · Cited by 158 · see citing works
Marek, G. J., Wright, R. A., Gewirtz, J. C., & Schoepp, D. D. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00199-3 · Cited by 158 · see citing works
Scruggs, J. L., Patel, S., Bubser, M., & Deutch, A. Y. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08846.2000 · Cited by 154 · see citing works
Molecular frequency filters at central synapses.
Thomson, A. (2000) · Progress in neurobiology · doi:10.1016/s0301-0082(00)00008-3 · Cited by 142 · see citing works
Varty, G. B., Bakshi, V. P., & Geyer, M. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00072-4 · Cited by 137 · see citing works
ROMANIDES, A., Duffy, P., & Kalivas, P. W. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00747-7 · Cited by 136 · see citing works
Yonezawa, Y., Kuroki, T., Kawahara, T., Tashiro, N., & Uchimura, H. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01435-0 · Cited by 133 · see citing works
Yan, Q., Reith, M. E. A., Jobe, P. C., & Dailey, J. W. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00568-4 · Cited by 131 · see citing works
Maurel-Remy, S., Bervoets, K. J. W., & Millan, M. J. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00333-g · Cited by 128 · see citing works
Scruggs, J. L., Schmidt, D. E., & Deutch, A. Y. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00547-0 · Cited by 126 · see citing works
Adams, B. W., & Moghaddam, B. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01195-7 · Cited by 124 · see citing works
Systemic PCP treatment elevates brain extracellular 5-HT
Martin, P., Carlsson, M. L., & Hjorth, S. (1998) · Neuroreport · doi:10.1097/00001756-199809140-00012 · Cited by 118 · see citing works
Suzuki, Y., Jodo, E., Takeuchi, S., Niwa, S., & Kayama, Y. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00298-1 · Cited by 115 · see citing works
Lada, M., Vickroy, T. W., & Kennedy, R. T. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70020617.x · Cited by 109 · see citing works
Autoreceptor Regulation of Glutamate and Aspartate Release from Slices of the Hippocampal CA1 Area
MARTIN, D. F., Bustos, G. A., Bowe, M. A., Bray, S. D., & Nadler, J. V. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02063.x · Cited by 103 · see citing works
Mirjana, C., Baviera, M., Invernizzi, R. W., & Balducci, C. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300479 · Cited by 102 · cited 4× · see citing works
“The fact that the same doses of M100,907 that prevent deficits in attentional performance (Carli et al. 2004) attenuate the effect of CPP on extracellular GLU (present study) suggests that the stimulation of GLU release may play a role in the attentional performance deficits caused by CPP.”
BackgroundInfluentialSelf-citationPresynaptic NMDA receptors in the neocortex are both auto- and heteroreceptors
Debiasi, S., Minelli, A., Melone, M., & Conti, F. (1996) · Neuroreport · doi:10.1097/00001756-199611040-00073 · Cited by 94 · see citing works
Liu, J., & Moghaddam, B. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10607-1 · Cited by 89 · see citing works
Martin, P., Waters, N., Schmidt, C. J., Carlsson, A., & Carlsson, M. L. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050064 · Cited by 86 · see citing works
Neuronal and glial localization of NMDA receptors in the cerebral cortex
Conti, F., Minelli, A., Debiasi, S., & Melone, M. (1997) · Molecular Neurobiology · doi:10.1007/bf02740618 · Cited by 86 · see citing works
MK‐801 Increases Extracellular 5‐Hydroxytryptamine in Rat Hippocampus and Striatum In Vivo
Whitton, P. S., Biggs, C. S., Pearce, B. R., et al. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb11381.x · Cited by 85 · see citing works
Abekawa, T., Ohmori, T., Ito, K., & Koyama, T. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02298-8 · Cited by 73 · see citing works
Zhai, Y. W., George, C. A., Zhai, J., Nisenbaum, E. S., Johnson, M. P., & Nisenbaum, L. K. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300013 · Cited by 71 · see citing works
Differential Effect of NMDA on Extracellular Serotonin in Rat Midbrain Raphe and Forebrain Sites
Tao, R., & Auerbach, S. B. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66031067.x · Cited by 70 · see citing works
Dijk, S. N., Francis, P. T., Stratmann, G. C., et al. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb15020.x · Cited by 70 · see citing works
R Wang, P. D. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00003-7 · Cited by 65 · see citing works
Maura, G., & Raiteri, M. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66010203.x · Cited by 62 · see citing works
Amargós‐Bosch, M., Adell, A., Bortolozzi, A. A., & Artigas, F. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02044.x · Cited by 61 · see citing works
Isomers of 2-amino-7-phosphonoheptanoic acid as antagonists of neuronal excitants
Ferkins, M. N., Collins, J. F., & Stone, T. W. (1982) · Neuroscience Letters · doi:10.1016/0304-3940(82)90230-0 · Cited by 61 · see citing works
Arco, A. D., & Mora, F. (1999) · Neurochemical Research · doi:10.1023/a:1021056826829 · Cited by 60 · see citing works
Srkalović, G., Selim, M., Rea, M. A., et al. (1994) · Brain Research · doi:10.1016/0006-8993(94)91474-5 · Cited by 58 · see citing works
Aura, J., & Riekkinen, P. (1999) · Neuroreport · doi:10.1097/00001756-199902050-00008 · Cited by 55 · see citing works
Pende, M., Lanza, M., Bonanno, G., et al. (1993) · Brain Research · doi:10.1016/0006-8993(93)90384-y · Cited by 54 · see citing works
Chapman, A. G., Meldrun, B. S., Nanji, N., et al. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90501-2 · Cited by 54 · see citing works
Renó, L. A. C., Zago, W. M., & Markus, R. P. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.12.023 · Cited by 52 · see citing works
Differential Interaction of Phencyclidine‐Like Drugs with the Dopamine Uptake Complex In Vivo
Maurice, T., Vignon, J., Kamenka, J., et al. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08185.x · Cited by 51 · see citing works
Arco, A. D., & Mora, F. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00758-4 · Cited by 51 · see citing works
Feenstra, M. G. P., Botterblom, M. H. A., & Uum, J. F. M. V. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00029-1 · Cited by 48 · see citing works
Kuroda, M., Murakami, K., Kishi, K., & Price, J. L. (1995) · The Journal of Comparative Neurology · doi:10.1002/cne.903560110 · Cited by 45 · see citing works
Corbett, R. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00128-1 · Cited by 42 · see citing works
Scott, D. O., & Heath, T. G. (1998) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(97)00144-1 · Cited by 42 · see citing works
Cozzi, N. V., & Nichols, D. E. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00325-1 · Cited by 38 · see citing works
Mediodorsal thalamic evoked responses in the rat prefrontal cortex
Pirot, S., Glowinski, J., & Thierry, A. M. (1996) · Neuroreport · doi:10.1097/00001756-199605310-00023 · Cited by 36 · see citing works
Connick, J. H., & Stone, T. W. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb11473.x · Cited by 36 · see citing works
Shi, W., & Zhang, X.-X. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046359 · Cited by 36 · see citing works
Perkinton, M. S., & Sihra, T. S. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70041513.x · Cited by 34 · see citing works
Expósito, I., Arco, A. D., Segovia, G., & Mora, F. (1999) · Neurochemical Research · doi:10.1023/a:1020901929419 · Cited by 32 · see citing works
Tao, R., & Hjorth, S. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb11010.x · Cited by 32 · see citing works
Abekawa, T., Honda, M., Ito, K., & Koyama, T. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1517-8 · Cited by 31 · see citing works
Habara, T., Hamamura, T., Miki, M., Ohashi, K., & Kuroda, S. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00926-8 · Cited by 27 · see citing works
Jodo, E., Suzuki, Y., Takeuchi, S., Niwa, S., & Kayama, Y. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03967-7 · Cited by 27 · see citing works
Carli, M., Baviera, M., Invernizzi, R. W., et al. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300545 · Cited by 22 · see citing works
Self-citationNabeshima, T., Ishikawa, K., Yamaguchi, K., et al. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90639-9 · Cited by 17 · see citing works
Sorbera, L. A., Silvestre, J. S., & Castañer, J. (1998) · Drugs of the Future · doi:10.1358/dof.1998.023.09.471198 · Cited by 14 · see citing works
Wang (1997) · doi:10.1002/(sici)1098-2396(199709)27:1
Flagged first, then by citations
Research works printed but not linked: 2
- Invernizzi R. W., Carli M., Baviera M. and Ceglia I. (2003) The 5-HT 2A receptor antagonist M100907 prevents the increase of cortical extracellular glutamate induced by the local infusion of the NMDA receptor antagonist CPP. In: Monitoring Molecules in Neuro- science. 10th International Conference on in vivo Methods (Kehr J., Fuxe K., Ungerstedt U. and Svensson T. H., eds), pp. 79-81. Karolinska University Press, Stockholm, Sweden.
- 5-HT 2A receptors and extracellular GLU 199 Ó 2004 International Society for Neurochemistry, J. Neurochem. (2004) 91, 189-199 14714159, 2004, 1, · DOI
Cited by
Sorted by citations
Sierra-Mercado, D., Padilla-Coreano, N., & Quirk, G. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.184 · Cited by 1,190 · see citing works
Thiele, A., & Bellgrove, M. A. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.008 · Cited by 350 · see citing works
Boulougouris, V., Glennon, J. C., & Robbins, T. W. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301584 · Cited by 219 · see citing works
Prefrontal cortex executive processes affected by stress in health and disease
Girotti, M., Adler, S. M., Bulin, S. E., Fucich, E. A., Paredes, D., & Morilak, D. A. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.07.004 · Cited by 176 · see citing works
The role of serotonin in the regulation of patience and impulsivity
Miyazaki, K., Miyazaki, K. W., & Doya, K. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8232-6 · Cited by 162 · see citing works
Serotonin and decision making processes
Homberg, J. R. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.06.001 · Cited by 167 · see citing works
Boulougouris, V., & Robbins, T. W. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4312-09.2010 · Cited by 136 · see citing works
“…in opposing changes in extracellular glutamate induced by the NMDA antagonist CPP [3-(2-carboxypiperazin-4-yl)propyl1-phosphonic acid] and attentional performance deficits in the 5CSRTT, indicating that 5-HT2A receptors of the mPFC are mainly involved (Ceglia et al., 2004; Carli et al., 2006).”
BackgroundThe potential role of lamotrigine in schizophrenia
Large, C. H., Webster, E. L., & Goff, D. C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0020-9 · Cited by 69 · see citing works
Calcagno, E., Carli, M., & Invernizzi, R. W. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03600.x · Cited by 54 · see citing works
Self-citationPozzi, L., Baviera, M., Sacchetti, G., Calcagno, E., Balducci, C., Invernizzi, R. W., & Carli, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2010.11.060 · Cited by 49 · see citing works
Self-citationCarli, M., Calcagno, E., Mainini, E., Arnt, J., & Invernizzi, R. W. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2066-6 · Cited by 20 · see citing works
Self-citationHunt, M. J., Olszewski, M., Piasecka, J., Whittington, M. A., & Kasicki, S. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4073-0 · Cited by 20 · see citing works
- Authors
- Ceglia, I., Carli, M., Baviera, M., Renoldi, G., Calcagno, E., & Invernizzi, R. W.
- Affiliations
- Mario Negri Institute for Pharmacological Research (IT)
- Corresponding author
- Invernizzi, Roberto W.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2004-09-06
- Volume
- 91
- Issue
- 1
- Pages
- 189-199
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1983842067
- Cited by
- 79
- References
- 101
- Citations by year
- 2024: 3 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 3 · 2019: 1 · 2018: 4 · 2017: 3 · 2016: 5 · 2015: 5 · 2014: 2 · 2013: 2 · 2012: 7
- FWCI
- 1.88
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- 5-HT2A receptor, NMDA receptor antagonists, CPP, extracellular glutamate, medial prefrontal cortex, glutamatergic neurotransmission, attention deficits, tetrodotoxin, cognitive impairment
- MeSH terms
- Analysis of Variance, Animals, Dose-Response Relationship, Drug, Drug Interactions, Extracellular Space, Fluorobenzenes, Male, Nicotine, Piperazines, Piperidines, Potassium Chloride, Serotonin, Serotonin Antagonists, Tetrodotoxin, 2-Amino-5-phosphonovalerate, Receptors, N-Methyl-D-Aspartate, Prefrontal Cortex, Microdialysis, Excitatory Amino Acid Antagonists, Glutamic Acid, Receptor, Serotonin, 5-HT2A, Rats, Serotonin 5-HT2 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review